AIM
ABBV icon

Alphinity Investment Management’s AbbVie ABBV Stock Holding History

Alphinity Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-131,060
Closed -$12.4M – 27
2018
Q1 		$12.4M Buy
131,060
+54,652
+72% +$6M 2.81% 22
2017
Q4 		$7.39M Buy
+76,408
New +$7.2M 6.63% 2

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alphinity Investment Management's ABBV Position: Q2 2018 in Review

Alphinity Investment Management sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 131,060 shares — an estimated $12.4M sold.

Alphinity Investment Management first reported a position in ABBV in Q4 2017 and held it in 2 quarters. The position peaked at $12.4M in Q1 2018. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

  • Alphinity Investment Management reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
  • Alphinity Investment Management sold 131,060 AbbVie shares in Q2 2018, an estimated $12.4M.
  • Alphinity Investment Management first reported a position in AbbVie in Q4 2017 and held it in 2 quarters.
  • Alphinity Investment Management's AbbVie position peaked at $12.4M in Q1 2018.
  • 1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Alphinity Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.